- Home
- MDRR vs NBY Comparison
MDRR vs NBY Comparison
Compare MDRR & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDRR
- NBY
- Stock Information
- Founded
- MDRR 2015
- NBY 2000
- Country
- MDRR United States
- NBY United States
- Employees
- MDRR N/A
- NBY N/A
- Industry
- MDRR Real Estate Investment Trusts
- NBY
- Sector
- MDRR Real Estate
- NBY
- Exchange
- MDRR Nasdaq
- NBY Nasdaq
- Market Cap
- MDRR 18.0M
- NBY 15.7M
- IPO Year
- MDRR 2018
- NBY 2007
- Fundamental
- Price
- MDRR N/A
- NBY $1.06
- Analyst Decision
- MDRR
- NBY Strong Buy
- Analyst Count
- MDRR 0
- NBY 1
- Target Price
- MDRR N/A
- NBY $0.85
- AVG Volume (30 Days)
- MDRR 1.3K
- NBY 575.4K
- Earning Date
- MDRR 11-11-2025
- NBY 11-06-2025
- Dividend Yield
- MDRR 2.01%
- NBY N/A
- EPS Growth
- MDRR N/A
- NBY N/A
- EPS
- MDRR N/A
- NBY 0.41
- Revenue
- MDRR $9,649,145.00
- NBY $9,781,000.00
- Revenue This Year
- MDRR N/A
- NBY $23.91
- Revenue Next Year
- MDRR N/A
- NBY $32.05
- P/E Ratio
- MDRR N/A
- NBY $2.90
- Revenue Growth
- MDRR N/A
- NBY 113.47
- 52 Week Low
- MDRR $9.55
- NBY $0.46
- 52 Week High
- MDRR $15.00
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- MDRR 52.34
- NBY 41.74
- Support Level
- MDRR $13.13
- NBY $0.99
- Resistance Level
- MDRR $13.99
- NBY $1.41
- Average True Range (ATR)
- MDRR 0.10
- NBY 0.17
- MACD
- MDRR -0.09
- NBY -0.07
- Stochastic Oscillator
- MDRR 36.87
- NBY 10.11
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.